Discovery of Potent and Orally Bioavailable Diaminoquinazoline-Derived mRNA Decapping Scavenger (DcpS) Enzyme Inhibitors for Treatment of Solid Tumors
Journal of Medicinal Chemistry · 13.08.2026 · 69 (15) · 19371-19389
DOI: 10.1021/acs.jmedchem.6c01711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 31.07.2026. Verfasst von Spencer O Scholz und 40 weiteren Autor:innen. Beteiligte Einrichtung: AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, California94080, United States. Hauptthemen laut MEDLINE: Antineoplastic Agents, Enzyme Inhibitors, Quinazolines, Endoribonucleases. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Decapping Scavenger (DcpS) enzyme, a pyrophosphatase involved in mRNA regulation via mRNA cap degradation, has been identified as a promising oncology target in fragile histidine triad (FHIT) deficient cancers such as AML and GBM but remains underexplored in broader solid tumor indications. We have discovered a novel DcpS inhibitor, compound 17, which has a differentiated binding mode relative to known inhibitors, engaging the second nucleotide-binding domain of the mRNA cap substrate. Compound 17 possesses superior levels of potency in NSCLC A549 cell line relative to known inhibitors and demonstrates excellent selectivity against DcpS-insensitive cell lines, high levels of bioavailability in preclinical species, and mitigated hERG liabilities. Finally, compound 17 demonstrates oral dose-dependent efficacy in two solid tumor xenograft models, A253 and EBC-1, highlighting the promise of DcpS as a novel target in FHIT low/deficient solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- AbbVie Bay Area, 1000 Gateway Boulevard, South San Francisco, California94080, United States.
- AbbVie, Inc., 1 N. Waukegan Road, North Chicago, Illinois60064, United States.
ORCID-Profile: Spencer O Scholz, Alexander S Dudnik, Aristidis Vasilopoulos, Brian S Brown, Caleb Karmel, Patrick B Brady, David G Belair
Zitieren
APA
Scholz, S. O., Dudnik, A. S., Vasilopoulos, A., Jia, Z. J., Albertson, A., Brown, B. S., Chen, L., Li, R., Ma, G., Wang, L., Okano, A., Zhao, X., Jiang, X., Karmel, C., Brady, P. B., Lai, C., Deokar, H., DeAnda, F., Roy, S., …, & Rivkin, A. (2026). Discovery of Potent and Orally Bioavailable Diaminoquinazoline-Derived mRNA Decapping Scavenger (DcpS) Enzyme Inhibitors for Treatment of Solid Tumors. Journal of Medicinal Chemistry, 69(15), 19371-19389. https://doi.org/10.1021/acs.jmedchem.6c01711
Vancouver
Scholz SO, Dudnik AS, Vasilopoulos A, Jia ZJ, Albertson A, Brown BS, et al. Discovery of Potent and Orally Bioavailable Diaminoquinazoline-Derived mRNA Decapping Scavenger (DcpS) Enzyme Inhibitors for Treatment of Solid Tumors. Journal of Medicinal Chemistry. 2026;69(15):19371-19389. doi:10.1021/acs.jmedchem.6c01711
BibTeX
@article{Scholz2026,
author = {Scholz, Spencer O and Dudnik, Alexander S and Vasilopoulos, Aristidis and Jia, Zhaozhong J and Albertson, Anna and Brown, Brian S and Chen, Liye and Li, Renhe and Ma, Gaoyuan and Wang, Longcheng and Okano, Akinori and Zhao, Xianrui and Jiang, Xingyu and Karmel, Caleb and Brady, Patrick B and Lai, Chunqiu and Deokar, Hemantkumar and DeAnda, Felix and Roy, Somdutta and Mayekar, Manasi and Choi, Hana and Lin, Louis and Belair, David G and Joshi, Anand and Yoon, Woo Hyun and Montano, Andrea and Xie, Xiaoping and Nguyen, Henry and Li, Haiyan S and Pan, Chin and Danna, Ben and Gurbani, Deepak and Li, Jingzhi and Korepanova, Alla and Li, Tao and Gururaja, Tarikere and Ding, Rong-Xian and Jain, Rinku and Martin, Ruth L and Kohnken, Rebecca and Rivkin, Alexey},
title = {Discovery of Potent and Orally Bioavailable Diaminoquinazoline-Derived mRNA Decapping Scavenger (DcpS) Enzyme Inhibitors for Treatment of Solid Tumors},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {15},
pages = {19371--19389},
doi = {10.1021/acs.jmedchem.6c01711}
}
EUVIMED